Literature DB >> 26201938

Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma.

Hideyuki Takahashi1, Koichi Sakakura1, Reika Kawabata-Iwakawa2, Susumu Rokudai3, Minoru Toyoda1, Masahiko Nishiyama3, Kazuaki Chikamatsu4.   

Abstract

Cancer-associated fibroblasts (CAFs) have been shown to play an important role in angiogenesis, invasion, and metastasis. In the present study, we determined whether CAFs within the tumor microenvironment (TME) in head and neck squamous cell carcinoma (HNSCC) contributed to promoting immunosuppression and evasion from immune surveillance. Six pairs of CAFs and normal fibroblasts (NFs) were established from the resected tumor tissues of patients with HNSCC. The effects of CAFs and NFs on the functions of T cells were comparatively analyzed. CAFs expressed the co-regulatory molecules, B7H1 and B7DC, whereas NFs did not. The expression levels of cytokine genes, including those for IL6, CXCL8, TNF, TGFB1, and VEGFA, were higher in CAFs. T cell proliferation was suppressed more by CAFs or their supernatants than by NFs. Moreover, PBMCs co-cultured with the supernatants of CAFs preferentially induced T cell apoptosis and regulatory T cells over those co-cultured with the supernatants of NFs. A microarray analysis revealed that the level of genes related to the leukocyte extravasation and paxillin signaling pathways was higher in CAFs than in NFs. These results demonstrated that CAFs collaborated with tumor cells in the TME to establish an immunosuppressive network that facilitated tumor evasion from immunological destruction.

Entities:  

Keywords:  Cancer-associated fibroblasts; Head and neck squamous cell carcinoma; Immunosuppression; Regulatory T cells; T cell apoptosis

Mesh:

Substances:

Year:  2015        PMID: 26201938     DOI: 10.1007/s00262-015-1742-0

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  37 in total

1.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

Review 2.  Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

Authors:  Joshua D Horton; Hannah M Knochelmann; Terry A Day; Chrystal M Paulos; David M Neskey
Journal:  Trends Cancer       Date:  2019-03-20

3.  Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.

Authors:  M Rita I Young; Corinne A Levingston; Sara D Johnson
Journal:  Int J Cancer       Date:  2016-01-28       Impact factor: 7.396

Review 4.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

Review 5.  Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses.

Authors:  Xin Pang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Oncol Lett       Date:  2018-08-17       Impact factor: 2.967

Review 6.  Nanomaterials for cancer immunotherapy.

Authors:  Wantong Song; Sara N Musetti; Leaf Huang
Journal:  Biomaterials       Date:  2017-09-17       Impact factor: 12.479

Review 7.  The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation.

Authors:  Drenka Trivanović; Jelena Krstić; Ivana Okić Djordjević; Slavko Mojsilović; Juan Francisco Santibanez; Diana Bugarski; Aleksandra Jauković
Journal:  Mediators Inflamm       Date:  2016-08-18       Impact factor: 4.711

8.  Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.

Authors:  Corinne A Levingston; M Rita I Young
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

Review 9.  Laryngeal Tumor Microenvironment.

Authors:  Georgia Karpathiou; Jean Marc Dumollard; Michel Peoc'h
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.

Authors:  Pei-Yu Chen; Wen-Fei Wei; Hong-Zhen Wu; Liang-Sheng Fan; Wei Wang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.